Vaxcyte, Inc.
Company Stats
- Market Cap
- $8.5B
- as of Sep 30, 2026
- Shares Outstanding
- 148.8M
- Free Float
- 95.0%
Income Statement
- Operating Income
- -$923.7M
- Net Income
- -$766.6M
- EBITDA
- -$907.3M
Cash Flow
- Free Cash Flow
- -$669.3M
- FCF Yield
- -7.9%
- Owner FCF Yield
- -9.5%
Balance Sheet
- Cash & Equivalents
- $174.0M
Returns & Capital
- SBC, 3Y Avg
- $90.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$669.3M | — |
| FY2024 | — | -$475.1M | — |
| FY2023 | — | -$312.9M | — |
| FY2022 | — | -$176.4M | — |
| FY2021 | — | -$127.9M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 2, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges